This episode examines the FDA’s final rule exempting certain radiology computer-aided detection devices from premarket notification, four new RapidAI clearances for neurovascular triage, and a twenty one percent improvement in breast cancer detection using multi-stage AI applied to digital breast tomosynthesis. Additional coverage includes FDA authorization for Pristina Recon DL’s deep learning-based mammography reconstruction, coronary plaque quantification software from Circle Cardiovascular Imaging, and athenahealth’s planned integration of Microsoft Dragon Copilot into ambient clinical documentation workflows. The briefing also addresses IQVIA’s agentic AI deployment on AWS infrastructure, Zimmer Biomet’s acquisition of Monogram Technologies’ robotic knee replacement platform, and Angle Health’s one hundred thirty four million dollar Series B round for employer benefits automation.
